BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21545550)

  • 21. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus-associated eosinophilic gastroenterocolitis in pediatric liver transplant recipients: role of potential food allergies in pathogenesis.
    Saeed SA; Integlia MJ; Pleskow RG; Calenda KA; Rohrer RJ; Dayal Y; Grand RJ
    Pediatr Transplant; 2006 Sep; 10(6):730-5. PubMed ID: 16911498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
    JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gingival enlargement in pediatric organ transplant recipients in relation to tacrolimus-based immunosuppressive regimens.
    Shiboski CH; Krishnan S; Besten PD; Golinveaux M; Kawada P; Tornabene A; Rosenthal P; Mathias R
    Pediatr Dent; 2009; 31(1):38-46. PubMed ID: 19320258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T; Storb R; Anasetti C; Appelbaum FR; Deeg HJ; Doney K; Martin P; Sullivan K; Witherspoon R; Nash RA
    Bone Marrow Transplant; 2000 Nov; 26(9):985-91. PubMed ID: 11100278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen.
    Irish W; Sherrill B; Brennan DC; Lowell J; Schnitzler M
    Transplantation; 2003 Dec; 76(12):1686-90. PubMed ID: 14688516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic spontaneous urticaria is not an allergic disease.
    Augey F; Gunera-Saad N; Bensaid B; Nosbaum A; Berard F; Nicolas JF
    Eur J Dermatol; 2011; 21(3):349-53. PubMed ID: 21616748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
    Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
    Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minor interference of cross-reactive carbohydrates with the diagnosis of respiratory allergy in standard clinical conditions.
    Vidal C; Sanmartín C; Armisén M; Rodríguez V; Linneberg A; Gonzalez-Quintela A
    Int Arch Allergy Immunol; 2012; 157(2):176-85. PubMed ID: 21986086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose metabolism before and after conversion from cyclosporine microemulsion to tacrolimus in stable renal recipients.
    Gelens MA; Christiaans MH; van Hooff JP
    Nephrol Dial Transplant; 2008 Feb; 23(2):701-6. PubMed ID: 17999993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression.
    Hernández D; Miquel R; Porrini E; Fernández A; González-Posada JM; Hortal L; Checa MD; Rodríguez A; García JJ; Rufino M; Torres A
    Transplantation; 2007 Sep; 84(6):706-14. PubMed ID: 17893603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical inflammation in renal transplant recipients: impact of cyclosporine microemulsion versus tacrolimus.
    Lauzurica R; Pastor MC; Bayes B; Malumbres S; Homs M; Llopis MA; Bonet J; Romero R
    Transplant Proc; 2007 Sep; 39(7):2170-2. PubMed ID: 17889127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cord serum immunoglobulin E as a risk factor for allergic symptoms and sensitization in children and young adults.
    Pesonen M; Kallio MJ; Siimes MA; Elg P; Björksten F; Ranki A
    Pediatr Allergy Immunol; 2009 Feb; 20(1):12-8. PubMed ID: 18298422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus.
    Ortega Suárez FJ; Sánchez Plumed J; Pérez Valentín MA; Pereira Palomo P; Muñoz Cepeda MA; Lorenzo Aguiar D;
    Nefrologia; 2011; 31(6):690-6. PubMed ID: 22130285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy outcomes in female patients exposed to cyclosporin-based versus tacrolimus-based immunosuppressive regimens after liver/kidney transplantation: A systematic review and meta-analysis.
    Gong X; Li J; Yan J; Dai R; Liu L; Chen P; Chen X
    J Clin Pharm Ther; 2021 Jun; 46(3):744-753. PubMed ID: 33386628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.